Authors


Robert F. Gaudette, PharmD, MBA Candidate 2016

Latest:

The Deadly "Sins" of Vaccinations: Avoiding Bloodborne Diseases

As pharmacists administer more vaccines, the risks of needle-stick injury and transmission of a bloodborne disease increase among pharmacists.


Sandeep Chaudhari, MS

Latest:

Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis Patients

Among rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.



April S. Brown, PharmD, RPh

Latest:

Understanding Vaccine Billing Changes for 2008

Recently announced changes in vaccine reimbursement under Medicare have implications for pharmacy billing processes.


Timothy O'Shea, MS, PharmD

Latest:

Overview of the Biosimilar Landscape

Biosimilars, which at the most simplistic level can be thought of as a type of generic option for a biologic, offer an opportunity to help reduce total biologic drug spend.




T. Joseph Mattingly II

Latest:

PharmD/MBA DEGREE: A PERFECT COMBINATION FOR ME...AND YOU?

Mr. Mattingly is a third-year professional student in the PharmD Program at the University of Kentucky College of Pharmacy and is dually enrolled in the MBA Program at the Gatton College of Business and Economics.


Hayato DeLellis, PharmD candidate

Latest:

Early Screening Is Key in Colorectal Cancer

New treatments with biological agents and vaccines are creating a pathway for patients with metastatic CRC.


Giang Ho, PharmD Candidate

Latest:

Graphic Pharmacy: A Student's Journey in Comics

Read the latest pharmacy comic from Giang Ho!


Samuel L. Ellis, PharmD, BCPS

Latest:

Advancing the Management of Diabetes: An Update on New Guidelines and Treatment Options

Pharmacists can learn about current management of type 2 diabetes mellitus, including updated clinical practice guidelines and the incorporation of new therapeutic classes into practice recommendations.


Katie Eder, Senior Editor

Latest:

7 OTC Product Categories Completely Covered by Insurance

Did you know that health plans completely cover certain OTC products when patients present a prescription?


Jennifer N. Clements, PharmD, BCPS, CDE

Latest:

Lipid Management When Converting Fluvastatin to Pravastatin: Medication Use Evaluation

There were no signifi cant differences in mean low-density lipoprotein cholesterol levels after patients were converted from fl uvastatin to pravastatin therapy.


Millie Mo, PharmD, BCPS

Latest:

Precision Medicine and the Pharmacist’s Role as a Trusted Counselor in Specialty Pharmacy

The placement of clinical pharmacists at the nexus of functional pharmacogenomics and in specialty pharmacy care makes good sense.


Keith Overfield

Latest:

Long-Term Care: Expanding Into the Market

Demonstrating success is critical to building a long-term care business. How can your pharmacy make a difference?


Edna Bowser, CPhT

Latest:

Joining a Pharmacy Organization Yields Benefits

Gaining the most value from membership requires active participation by techs and a willingness to go outside their comfort zones.



Anthony Palmieri, PharmD, MBA

Latest:

The Impact of Abuse Deterrent Technologies on Prescription Opioid Trends

The authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.


Marcy T. Holler, PharmD, CPP, BCPS

Latest:

Treatment of Microalbuminuria in Patients with Type 2 Diabetes in the Absence of Hypertension

In some circumstances, antihypertensives can play a role in treatment even when a patient's blood pressure readings are normal.


Anthony Mazzarese, PharmD, MSPBA

Latest:

Will Specialty Pharmacies Be Needed in the Future?

Drug development and innovation could render the current specialty pharmacy model obsolete in 20 years.


R. Scott Leslie, MPH

Latest:

Patient Characteristics and Medication Burden Affect Adherence Among Seniors

Adherence among seniors to 3 widely used chronic medication classes differed by medication burden, patient characteristics, and specific comorbid conditions.


Les Paul, MD, MS

Latest:

Healthcare Reform, Comparative Effectiveness Research, and P&T Decisions

The conduct and interpretation of comparative effectiveness research must build confidence that this research will enable improved access to appropriate healthcare interventions.


Jenine Abuzir, PharmD Candidate

Latest:

The Value of Student Teachers in Pharmacy School

There is no greater support team available to students than their pharmacy school.


Rena Bielinski, PharmD, AHFI

Latest:

Behavioral Analytics: Key to Shutting Down the Medicare Part D ATM

Advanced behavioral analytics can differentiate patterns of fraud and abuse from instances such as oncology patients receiving multiple prescriptions from different specialists.



Maria R. Baer, MD

Latest:

Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related Therapies

Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.


Harold Laudien

Latest:

HEALTH SAVINGS ACCOUNTS: AN ANSWER TO RISING HEALTH CARE COSTS

Mr. Laudien is a financial advisor with Merrill Lynch in Princeton, NJ, member of Securities Investor Protection Corp.


Marile L. Santamarina, MS, PharmD, CPh

Latest:

Prescription Drug Adherence: A "Challenge" for So Many…

Poor medication compliance in chronic diseases in a well-known public health problem. Pharmacists play a key role in optimizing medication use in patients with chronic conditions.